lost in pennyland
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I haven't seen anything substantial lately except that I think they're going to test their new panels in space to see how well they work. The Carl Pope editorial could be a sign of the direction that ENSL is heading (that is, of course, if they ever do anything).
I just received a package in the mail for the shares of trusts of Lehman stock that I owned a couple of years ago. Anyone have any idea what the shares are worth, and has anyone else received a packet about their Lehman shares?
Why is this not good news for GERS? If they're using GERS' technology then GERS will reap the benefit of their business.
How much are they owed by ICM and all the others in total?
So GERS has made $12,470,864 in the last 9 months. It has an EPS of $6.08. The P/E is .02. So a P/E of 10 is $60 a share. Maybe this has legs.
When does the dilution resume, or is this company finally going to be a friend to the shareholder?
They don't need a reverse split. If the trials go well, this will be a nasdaq company and then some. Thanks again for all your posts. All you have to do is read your posts and you're pretty much up to speed here.
So it looks like the share count, including all of the lawsuit shares will be about 2.2 billion?
I only read a few of your posts. Did I pass the test, or what is the correct answer professor Rocky of ACTC 101?
And then what is the market value?
Wowsa, this one's getting fun, huh? About time for some of you old-timers. Good call longs!
Oops, I was going to add ACTC to the sure things list, but I already did that at .10. Might have to add a double sure things category...
You've read the NY times piece on Gelbaum, right? If you haven't I recommend it. Also the piece by Carl Pope on third world countries was interesting (I re-posted it a few posts back).
I like your niche observation. The info posted by tet and soc on the yahoo board about other companies' solar projects has had me worried about all the competing products out there.
The longer we wait the more I wonder about whether Entech can compete.
ENSL is trading with all of the other solar stocks. FSLR went down about 66% off of it's all-time high to finish 2011. ENSL went down 80+% from it's 52 week high to finish 2011. Now all solars are moving higher on news that inventories have been cleared out due to high demand for solar.
Financial analyst Gordon Johnson, who predicted armageddon 14 months ago for the solar industry, has turned neutral on solar from his sell rating.
http://www.businessweek.com/news/2012-01-17/solar-slump-ending-says-axiom-analyst-who-predicted-armageddon.html
Chart is definitely getting better. Do you see something that marks a bottom or reversal?
http://e360.yale.edu/feature/solar_power_off_the_grid_energy_access_for_words_poor/2480/
Great article from tet on the yahoo board. It's starting to get exciting in the solar world... and a little bit of light is starting to shine on the stock price too.
Up 40% on the highest volume day since the spring high of .10. I think we have reached the turning point.
Nearing double zeroes now. Perhaps a little tax-loss selling will help us reach the next frontier...
The 8K from 12/1/11 lists a convertible note for $400,000 with an exersize price of .05. You can buy shares on the open market currently for less than a third of the price that the Quercus trust just paid to lend the company money - interest free.
Remarkable.
It's a conservative target, but it fits nicely with the five year chart. There should be a nice spike as this heads to ODAC eventually...
Continuing to steadily sink ... and stink.
This could go on for months, if not years...
Updated ACTC.
Yep, there's the run. Now after this slows down watch for the next RS.
Only a man with that many eyes would invest in Greenshift these days. It takes at least four eyes to see any future return on investment here.
Of course, the extra ones only see imaginary stuff. Why, I remember when people use to pay $8,000,000 a share back in '98...
Another resignation - this time a director. I think we sink silently to the bottom - .0001. And then?
Added ACTC to the Sure things list.
Added ACTC to the winners list.
Added NWBO to the longshots list.
It occured to me today that Lanza's "Sometimes it's the second mouse that gets the cheese" was more than just a metaphor, it was a scientific observation.
Lanza spent years studying mouse behavior.
In order to determine whether the treatment worked he had to know definitively how a blind mouse would perform on his test versus a mouse with sight. When the cells were injected into the eyes of blind mice, it became obvious because they clearly started to react to his test like mice that could see. The blind mice were now able to get the cheese, but only the blind mice that received the cells.
Their only cue was light.
Lanza knew it would be more difficult for Geron to succeed in their trial. Now will the second mouse get the cheese?
I believe ACTC will get'er done. I do believe this will double on good news soon...
Remember, ACTC is developing their blood cells using embryonic stem cells, not bone marrow.
I think even lower risk now that someone pointed out the $10,000,000 in the 10Q that would go to ENSL in the event that David dies.
To me that says no BK.
I'm holding and adding if I get good feedback. David is virtually impossible to get a hold of apparently, and will only call you if you're working on a new technology that he is interested in. The company doesn't respond either.
This could very well be one of the guys who was just let go selling, or it could be a big holder with little information who is spooked by the termination of the CFO and COO positions.
Could be a great buying opportunity.
So a more apt name would be the Sociopath Club or Sociopath Capital. Why can't people just be honest? Any company would be proud to do business with a company that was completly open about their sordid past and their true nature.
Why, I'd be proud to invest in a company funded and owned by Sociopath Capital.
Someone appears to be panic-selling. It's understandable in light of the recent discontinuation of the COO and CTO positions. What happens from here? The company appears to be winding down operations. Does it get sold to one of Gelbaum's other companys? SOEN?
I don't think this ends in bankruptcy, but ENSL appears to be ending soon in some fashion.
David Gelbaum, CEO, said, "Mark O'Neill is the smartest person I've met in the field of solar optics. He wields the Second Law of Thermodynamics like a sword. If there was such a prize and I could do so, I would nominate him for the Nobel Prize in Solar Optics."
Imagine how elated we would be if someone of O'Neill's credentials was joining the company. We already have him...
And Entech continues to languish in obscurity.
My bad. I thought it was his company merging in. So this is just an RS with no reverse merger?
I talked to Shawn briefly. I asked if the VAEV shell was available. He said he wasn't involved with it and that I needed to talk to Lloyd. Since his company is supposed to be merging into VAEV, it sounded to me like the deal was off.
If Shogun was merging in, I would expect that Shawn wouldn't want me calling Lloyd about merging in a different company.
But it was probably wishful thinking on my part. It's probably a done deal like the other guys were saying. It looks like a completely crappy deal for shareholders. It's a shame because with a good merger, this would be a goldmine at this price.
I think the 300 to 1 split is off for now. Sounds like the deal with Shogun may be dead. A more shareholder friendly merger was offered, and apparently he was open to the proposal.
With less than 70 million shares outstanding, a reverse split didn't make much sense anyway.
I see they predicted $6,000,000 in revs for 2011 and produced less than $600,000. Whatta got for 2012?
No that's fact. If you've been around penny stocks for years like I have, it's an obvious truth. In fact it's a law by now.
Now for some more facts...
1. This company has consistently crapped on shareholders for it's entire four year existence as a public company.
2. Reverse splits and penny stocks are a recipe for losing money.
What percent return do you expect from the current price of .152 over the next five years?
No effect, MCET does not use embryonic stem cells.